In this podcast, Dr. Vamsidhar Velcheti discusses an early study on a new targeted therapy for non-small cell lung cancer.
ASCO Annual Meeting 2019: Laparoscopic Surgery for Metastatic Colorectal Cancer, Expanding Eligibility Criteria for Advanced Non-Small Cell Lung Cancer, and a New Targeted Therapy for Advanced Bladder Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer.
ASCO Annual Meeting 2019: Immunotherapy for Lung Cancer, Gastrointestinal Cancers and Targeted Therapy for Breast Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include treatment advances for advanced lung cancer, stomach cancer, gastroesophageal junction cancer, and breast cancer.
The stigma of lung cancer has powerful consequences for those diagnosed with the disease. Dr. Narjust Duma shares the story of a patient who was brave in the face of lung cancer but feared the judgment of her community.
Following an exercise program during and after lung cancer treatment may help reduce cancer-related fatigue and speed recovery from treatment. Read about 4 types of exercise to consider and why.
Lung cancer affects tens of thousands of Americans every year. In this blog post, Lineagotica Associate Editor Dr. Jyoti Patel describes 9 things every person should know about lung cancer.
ASCO Annual Meeting 2018: Less Treatment Needed for Some Patients With Breast Cancer and Kidney Cancer, Immunotherapy for Non-Small Cell Lung Cancer, and Maintenance Chemotherapy for Rhabdomyosarcoma
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include new treatment options and improved survival for breast cancer, kidney cancer, non-small cell lung cancer, and rhabdomyosarcoma.
ASCO Annual Meeting 2018: New Insight Into Lynch Syndrome, Finding and Treating Lung Cancer, a New Targeted Therapy for Breast Cancer, and Evidence that Personalized Medicine Helps
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights address the connection between microsatellite instability and Lynch syndrome, a blood test that may be used to find early lung cancer, a new targeted therapy for treating advanced breast cancer, an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people with cancer live longer.
ASCO President Dr. Bruce E. Johnson has gone to the ASCO Annual Meeting for 34 years. In this video, he describes one of the most memorable research presentations he’s seen and how the research presented at this meeting each year changes patients’ lives.